References
- Sawaya GF, Brown AD, Washington AE, et al. Clinical practice: current approaches to cervical-cancer screening. N Engl J Med 2001; 344(21): 1603–7
- Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132(2): 277–84
- ACOG committee opinion. Recommendations on frequency of Pap test screening. No. 152, March 1995. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1995; 49(2): 210–1
- US Preventive Services Task Force. Guide to clinical preventive services: report of the US Preventive Services Task Force. 2nd ed. Baltimore: Williams and Wilkins, 1996. Available at: http://www.ahrq.gov/clinic/cpsix.htm. Accessed Nov 15, 2002
- Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52(6): 342–62
- Pearce KF, Haefner HK, Sarwar SF, et al. Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease. N Engl J Med 1996; 335(21): 1559–62
- Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189(1): 12–9
- Unger ER, Duarte-Franco E. Human papillomaviruses: into the new millennium. Obstet Gynecol Clin North Am 2001; 28(4): 653–66
- Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93(4): 293–9
- Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287(16): 2114–9
- Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287(16): 2120–9
- Richart RM. A sea change in diagnosing and managing HPV and cervical disease—part 1. Contemp OB/GYN 2002; 5: 42–56